NCO-90
NCO-90 is a selective SIRT2 inhibitor with an IC50 of 1.0 μM. NCO-90 induces Apoptosis via Caspase activation and mitochondrial superoxide anion production, and also induces Autophagic cell death by increasing LC3-II levels and autophagosome accumulation. NCO-90 exhibits anticancer activity against leukemia. NCO-90 can be used in research related to acute lymphoblastic leukemia and acute myeloid leukemia.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1382354-18-8
- Formel: C21H20N2O2
- Molecular Weight:332.40
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Caspase Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[2]|
SIRT2 1.0 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MCF7 | GI |
30 %
Compound: NCO-90
|
Growth inhibition of human MCF7 cells at 30 uM measured after 72 hrs by AlamarBlue assay relative to control
Growth inhibition of human MCF7 cells at 30 uM measured after 72 hrs by AlamarBlue assay relative to control
|
[PMID: 31144814] |
In Vitro
NCO-90 potently and selectively inhibits purified SIRT2 with an IC50 of 1.74 μM, while exerting no significant inhibitory effect on SIRT1, SIRT3 or SIRT5[1].
NCO-90 is a selective SIRT2 inhibitor with an IC50 of 1.0 μM[2].
NCO-90 (0.1-100 μM; 72 h) inhibits the growth of S1T, MT-2, Jurkat and HL60 leukemia cell lines in a dose-dependent manner, with GI50 values of 38.3 μM, 48.5 μM, 48.2 μM and 40.2 μM, respectively[2].
NCO-90 (0.1-100 μM; 72 h) induces apoptosis in S1T, MT-2, Jurkat and HL60 leukemia cell lines in a dose-dependent manner, with 100 μM NCO-90 increasing the proportion of annexin V-positive specific cells in the above cell lines to 52.5%, 34.7%, 42.3% and 66.5%, respectively[2].
NCO-90 (6 h) induces mitochondrial superoxide anion production in S1T, MT-2, Jurkat and HL60 leukemia cell lines[2].
NCO-90 (50 μM; 72 h) induces both caspase-dependent and caspase-independent cell death in S1T, MT-2, Jurkat and HL60 leukemia cell lines, as Z-VAD-FMK fails to inhibit NCO-90-induced cell death, apoptosis, DNA fragmentation or caspase activation[2].
NCO-90 (72 h) increases the level of acetylated histone H4K16 and promotes the degradation of nuclear p53 in S1T, MT-2, Jurkat and HL60 leukemia cell lines[2].
NCO-90 (25-100 μM; 24-48 h) induces autophagy and autophagosome accumulation in S1T, MT-2, Jurkat and HL60 leukemia cell lines, which is characterized by increased LC3-II levels, enhanced Cyto-ID fluorescence, and inhibited autophagosome degradation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:S1T (HTLV-1-infected CD4+ T-cell line), MT-2 (HTLV-1-infected T-cell line), Jurkat (T-lineage acute lymphoblastic leukemia cell line), HL60 (acute myeloid leukemia cell line)
-
Concentration:0.1-100 μM
-
Incubation Time:72 h
-
Result:Inhibited the growth of all four leukemic cell lines in a dose-dependent manner.
Achieved GI50 values of 38.3 μM for S1T cells, 48.5 μM for MT-2 cells, 48.2 μM for Jurkat cells, and 40.2 μM for HL60 cells.
-
Cell Line:S1T, MT-2, Jurkat, HL60 leukemic cell lines
-
Concentration:0.1-100 μM
-
Incubation Time:72 h
-
Result:Induced a dose-dependent increase in annexin V-positive cells across all four cell lines.
Generated 52.5% specific annexin V-positive cells in S1T cells, 34.7% in MT-2 cells, 42.3% in Jurkat cells, and 66.5% in HL60 cells at 100 μM.
Induced early-phase apoptosis (annexin V+/7-amino-actinomycin D- cells) and DNA fragmentation detected via TUNEL assay.
-
Cell Line:S1T, MT-2, Jurkat, HL60 leukemic cell lines
-
Concentration:25-100 μM (Cyto-ID and western blot assays); 50 μM (autophagic flux analysis)
-
Incubation Time:48 h (Cyto-ID and western blot assays); 24 h (autophagic flux analysis)
-
Result:Increased autophagy levels (measured by Cyto-ID fluorescence) and significantly increased LC3-II (lapidated LC3) levels across all four cell lines.
Induced LC3 translocation and inhibited autophagosome degradation shown by autophagic flux analysis.
Chemical Information
-
CAS. Nr. 1382354-18-8
-
Molecular Weight 332.40
-
Formel C21H20N2O2
-
SMILES
O=C(C1=C(NC2=CC(OCCC3=CC=CC=C3)=CC=C2)C=CC=C1)N
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Reinheit & Dokumentation
Verweise
[1]. Itoh Y. Drug Discovery Researches on Modulators of Lysine-Modifying Enzymes Based on Strategic Chemistry Approaches. Chem Pharm Bull (Tokyo). 2020;68(1):34-45. [Content Brief]
[2]. Kozako T, et al. Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines. BMC Cancer. 2018;18(1):791. Published 2018 Aug 6. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)